1. Home
  2. /
  3. Availability
  4. /
  5. Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.

Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.

Description

From 2023 onwards we modelled a combination of interventions acting at different stages of the care cascade, including improved diagnostics; reducing the patient care seeking delay; and the rollout of a disease-preventing vaccine from 2025 onwards.
TB vaccine theme
Availability
Epidemiological impact

Project details

Country
Afghanistan, Bangladesh, Cambodia, CD, Ethiopia, India, Indonesia, Kenya, Kyrgyzstan, Malawi, Mozambique, Myanmar, Nigeria, Pakistan, Philippines, South Africa, Tajikistan, Tanzania, Uganda, Ukraine, Uzbekistan, Vietnam, Zambia, Zimbabwe
Timeline
2023
Target group
Adolescents, Adults
Vaccine
Hypothetical vaccines
Type of protection of vaccine
Prevention of disease
Type of research
Modelling
Partners involved
Imperial college, USAID
Type of project
research
Funder
Civil Society
Governmental Body

Resources

Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.

Contact

Joeri Buis
joeri.buis@kncvtbc.org
Click to copy link of this header Menu